AntoXa

Life-saving biodefense solutions

  • About Us
    • Management Team
  • Products
  • Investors
  • News
  • Contact
You are here: Home / Contact

Contact

To learn more about AntoXa Corporation, please contact:

Don Stewart, CEO
[email protected]
416.452.7242

Ashley J. Meyers, President and Chief Operating Officer
[email protected]
905.852.0850
1920 Yonge Street, Suite 200 Toronto, Ontario, Canada, M4S 3E2

For media inquiries, please contact:

Stacey Curry Gunn
Director of Communications
[email protected]
519.827.1131

Questions? Drop us a line via our Contact Form:

Latest News

AntoXa and SwiftPharma to present plant-made anti-ricin antibody technology to NATO expert panel

August 14, 2024

GUELPH, Ont., Canada, August 14, 2024 — AntoXa Corporation, a Canadian ...
Read more >

New Patent for AntoXa’s Plant-Made Anti-Ricin Antibody Manufacturing Process

January 30, 2024

GUELPH, Ont., Canada, January 30, 2024 — The Canadian Intellectual ...
Read more >

AntoXa Corporation and SwiftPharma Sign Exclusive Collaboration Agreement to Support the Development and Commercialization of a Plant-Made Antibody Against Ricin Exposure

September 5, 2023

GHENT, Belgium and TORONTO, Canada, September 5, 2023 – AntoXa ...
Read more >

About Us

Plant-made biopharmaceuticals for a safer world. AntoXa Corporation is a Canadian biopharmaceutical company developing medical countermeasures to protect military and civilian personnel from biological and chemical agents that might be used in terrorist attacks, as well as outbreaks of naturally ...
Read more >

Global Demand for Biodefense Therapeutics

Governments are investing billions of dollars preparing for potential bioterrorism attacks and ...
Read more >

Subscribe to our Newsletter

vivoXPRESS® MANUFACTURING SYSTEM
The plant-based vivoXPRESS® manufacturing platform offers several advantages over the mammalian and bacterial cell culture systems used to produce most recombinant protein pharmaceuticals. Here’s how it works.

BioPharming Info Centre

Biopharming, also known as plant molecular farming, refers to the use of genetically modified plants to produce a wide range of pharmaceuticals and industrial products. See our Biopharming Info Centre to Learn more about the science and history of using plants to produce complex therapeutic proteins.

Copyright © 2025 · AntoXa Corporation | Site by Curry Gunn & Associates